;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Applied Genetic raises $30 million in follow-on

    Rare ophthalmic disease company Applied Genetic Technologies Corp. (NASDAQ:AGTC) raised $30 million through the sale of 2 million shares at $15 in a follow-on underwritten by BMO Capital Markets; Stifel; Wedbush PacGrow…

    Published on 7/25/2014
  • FINANCIAL NEWS: Ocular, Innocoll take haircuts to get out IPO door

    Ocular Therapeutix Inc. (NASDAQ:OCUL) and Innocoll GmbH (NASDAQ:INNL) priced IPOs on Friday. Ocular raised $65 million through the sale of 5 million shares at $13. The price values the company at $267.4 million. Earlier…

    Published on 7/25/2014
  • FINANCIAL NEWS: Alexion reports 2Q14 earnings, EMA to review asfotase alfa

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) reported 2Q14 earnings that beat the Street on Thursday and separately said EMA accepted and granted accelerated assessment to an MAA for asfotase alfa to treat …

    Published on 7/24/2014
  • FINANCIAL NEWS: Atox Bio closes $23 million in E round

    Infectious disease play Atox Bio Inc. (Ness Ziona, Israel) raised an undisclosed amount in the first tranche of a $23 million series E round led by new investor SR One. New investors Lundbeckfond Ventures and OrbiMed …

    Published on 7/24/2014
  • FINANCIAL NEWS: Celgene tops Street estimates, raises guidance

    Celgene Corp. (NASDAQ:CELG) reported 2Q14 earnings that beat the Street on Thursday and raised its full-year EPS and revenue guidance. The company reported 2Q14 adjusted diluted EPS of $0.90, beating by a penny the …

    Published on 7/24/2014
  • FINANCIAL NEWS: Imaging play Lantheus sets IPO terms

    Lantheus Holdings Inc. (North Billerica, Mass.) amended its planned IPO on NASDAQ and now plans to sell 9.3 million shares at $12-$15. At the $13.50 midpoint, the company would raise $125 million and be valued at $369.1…

    Published on 7/24/2014
  • FINANCIAL NEWS: Immune Design, Pfenex price IPOs

    Cancer immunotherapy company Immune Design Corp. (NASDAQ:IMDZ) and biosimilar play Pfenex Inc. (NYSE:PFNX) priced their IPOs on Thursday. Immune Design raised $60 million through the sale of a bumped-up number of shares…

    Published on 7/24/2014
  • FINANCIAL NEWS: Infectious disease play ContraFect amends IPO

    ContraFect Corp. (Yonkers, N.Y.) again amended its IPO and now plans to sell 5.5 million units at $5-$6 on NASDAQ. At the $5.50 midpoint, the company would raise $30 million. Each unit comprises a share, a class A …

    Published on 7/24/2014
  • FINANCIAL NEWS: Intersect raises $55 million in IPO

    Intersect ENT Inc. (NASDAQ:XENT) was up $1.92 (17%) to $12.92 on its first day of trading Thursday after raising $55 million through the sale of 5 million shares at $11 in an IPO. The $11 price valued the drug-delivery …

    Published on 7/24/2014
  • FINANCIAL NEWS: Biogen Idec jumps on 2Q14 results

    Biogen Idec Inc. (NASDAQ:BIIB) gained $33.93 (11%) to $337.60 on Wednesday after reporting 2Q14 financial results that beat consensus EPS and sales estimates. The move translates to a gain of $8 billion in market cap …

    Published on 7/23/2014
  • FINANCIAL NEWS: GSK reports 2Q14 results, lowers 2014 guidance

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) reported 2Q14 financial results on Wednesday that missed consensus EPS and sales estimates; the pharma also lowered its 2014 guidance. The pharma's 2Q14 core EPS dropped 12% to 19…

    Published on 7/23/2014
  • FINANCIAL NEWS: KineMed pulls IPO

    Biomarker discovery company KineMed Inc. (Emeryville, Calif.) withdrew its IPO on NASDAQ, citing "market conditions." The company declined to comment on future financing plans. Last month, KineMed amended its IPO to …

    Published on 7/23/2014
  • FINANCIAL NEWS: La Jolla raises $50.4 million in follow-on

    La Jolla Pharmaceutical Co. (NASDAQ:LJPC) raised $50.4 million through the sale of 4.8 million shares at $10.50 in a follow-on underwritten by Jefferies; Chardan Capital Markets; H.C. Wainwright; LifeSci Capital; and …

    Published on 7/23/2014
  • FINANCIAL NEWS: Puma soars on neratinib news

    Puma Biotechnology Inc. (NYSE:PBYI) jumped $174.40 (295%) to $233.43 on Wednesday after the company reported top-line data for oral neratinib (PB272) as adjuvant treatment of HER2-positive breast cancer late Tuesday and…

    Published on 7/23/2014
  • FINANCIAL NEWS: Remiges raises $70 million for $150 million fund

    Remiges Ventures has raised $70 million of the targeted $150 million in its Remiges BioPharma Fund L.P., according to an SEC filing. The firm will invest in early stage companies in the U.S. and Europe that are …

    Published on 7/23/2014
  • FINANCIAL NEWS: Sofinnova raises $500 million for ninth fund

    Sofinnova Ventures raised $500 million for Sofinnova Venture Partners IX, its ninth fund and second life sciences-only fund. The firm was targeting $425 million for the fund, which was oversubscribed. Sofinnova plans to…

    Published on 7/23/2014
  • FINANCIAL NEWS: Actelion reports 17% sales increase in first half

    Actelion Ltd. (SIX:ATLN) reported total sales of CHF993 million ($1.1 billion) in the first half, a 17% increase compared to the same year-ago period. Core EPS rose by 48% in constant currency to CHF3.25. Actelion …

    Published on 7/22/2014
  • FINANCIAL NEWS: CymaBay raises $22 million in follow-on

    CymaBay Therapeutics Inc. (NASDAQ:CBAY) raised $22 million through the sale of 4 million shares at $5.50 in a follow-on underwritten by Cowen; Stifel; Roth Capital Partners; and National Securities. CymaBay's …

    Published on 7/22/2014
  • FINANCIAL NEWS: Mela Sciences proposes to raise $27.3 million

    Mela Sciences Inc. (NASDAQ:MELA) plans to raise $27.3 million though the sale of about $15 million in senior secured convertible debentures and 12,300 shares of series B convertible preferred stock at $1,000 in a …

    Published on 7/22/2014
  • FINANCIAL NEWS: Orthocell raises A$8 million in Australian IPO

    Regenerative medicine play Orthocell Ltd. (ASX:OCC) raised A$8 million ($7.5 million) through the sale of 20 million shares at A$0.40 in an IPO on the Australian Stock Exchange. The price values the company at A$33 …

    Published on 7/22/2014
  • FINANCIAL NEWS: Synlogic secures $29.4 million series A

    Synlogic Inc. (Cambridge, Mass.) raised an undisclosed amount in a tranched $29.4 million series A round co-led by existing investor Atlas Venture and new investor New Enterprise Associates. Synlogic is developing …

    Published on 7/22/2014
  • FINANCIAL NEWS: Allergan beats Street, to cut 13% of workforce

    Allergan Inc. (NYSE:AGN) reported 2Q14 financial results on Monday that beat the Street but said the company will reduce headcount by about 1,500 (13%) to about 10,200. The cuts include about 700 R&D positions and about…

    Published on 7/21/2014
  • FINANCIAL NEWS: Auris, Avalanche, Tobira, Loxo set IPO terms

    Audiology company Auris Medical AG (Zug, Switzerland), ophthalmic play Avalanche Biotechnologies Inc. (Menlo Park, Calif.), infectious disease company Tobira Therapeutics Inc. (San Francisco, Calif.) and Loxo Oncology …

    Published on 7/21/2014
  • FINANCIAL NEWS: CareDx raises $40 million in IPO

    Molecular diagnostics company CareDx Inc. (NASDAQ:CDNA) raised $40 million through the sale of 4 million shares at $10 in an IPO. The price values the company at $115.7 million. Earlier this month, CareDx said it …

    Published on 7/18/2014
  • FINANCIAL NEWS: Catalent sets terms for NYSE IPO

    Catalent Inc. (Somerset, N.J.) said it plans to sell 42.5 million shares at $19-$22 in an IPO on the NYSE. At the $20.50 midpoint, the company would raise $871.3 million and be valued at $2.4 billion. Catalent filed to …

    Published on 7/18/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993